ArticlePharmaceuticals (Basel, Switzerland)2021

Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells.

Joelle C Boulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.